Repligen's exclusive partnerships with companies such as DRS Daylight Solutions and Purolite give it a competitive edge in the industry. The company's diverse product line includes pre-packed columns, ...

Repligen said today it has acquired TangenX Technology from Novasep Holding for $39 million in a deal that adds to the bioprocessing company’s single-use technology offerings and broadens its ...

Years ago, Peter Lynch popularized the concept of “picks and shovels,” noting that most of the miners who joined the Gold Rush to get rich failed to do so, but the people who focused instead on ...

WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...

WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have ...

WALTHAM, Mass.—Whether researching gene therapy, developing a therapeutic drug for a debilitating illness or discovering a possible vaccine for COVID-19, there is a need for bioprocessing tools and ...

DELRAY BEACH, Fla., Aug. 21, 2025 /PRNewswire/ -- The global Tangential Flow Filtration Market, valued at US$1.76 billion in 2024, stood at US$1.86 billion in 2025 and is projected to advance at a ...

A therapeutic protein or monoclonal antibody (mAb) can be turned into an effective therapy and a revenue-generating product only if it can be efficiently filtered from the process stream. If a product ...

Investing.com - KeyBanc reiterated its Overweight rating and $220.00 price target on Repligen (NASDAQ:RGEN) on Tuesday, highlighting the company’s differentiated filtration portfolio. Currently ...